| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |